American Century Companies Inc Amicus Therapeutics, Inc. Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 3,904,657 shares of FOLD stock, worth $35.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,904,657

Previous 3,923,465 0.48%

Holding current value

$35.2 Million

Previous $38.9 Million 7.15%

% of portfolio

0.02%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$9.55 - $12.09 $179,616 - $227,388	-18,808 Reduced 0.48%	3,904,657 $41.7 Million
Q2 2024 Aug 07, 2024	SELL	$9.04 - $11.75 $7.93 Million - $10.3 Million	-877,434 Reduced 18.28%	3,923,465 $38.9 Million
Q1 2024 May 14, 2024	BUY	$11.43 - $14.24 $2.5 Million - $3.12 Million	218,832 Added 4.78%	4,800,899 $56.6 Million
Q4 2023 Feb 13, 2024	BUY	$9.97 - $14.52 $45.7 Million - $66.5 Million	4,582,067 New	4,582,067 $65 Million
Q3 2023 Nov 13, 2023	BUY	$11.78 - $13.86 $5.06 Million - $5.95 Million	429,257 Added 10.97%	4,343,870 $52.8 Million
Q2 2023 Aug 14, 2023	BUY	$10.72 - $13.3 $42 Million - $52.1 Million	3,914,613 New	3,914,613 $49.2 Million
Q2 2022 Aug 12, 2022	BUY	$6.23 - $11.12 $307,388 - $548,660	49,340 New	49,340 $530,000
Q1 2021 May 14, 2021	SELL	$9.2 - $23.86 $7.43 Million - $19.3 Million	-807,412 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$13.47 - $24.89 $12,190 - $22,525	-905 Reduced 0.11%	807,412 $18.6 Million
Q3 2020 Nov 13, 2020	SELL	$12.89 - $15.89 $985,685 - $1.22 Million	-76,469 Reduced 8.64%	808,317 $11.4 Million
Q2 2020 Aug 13, 2020	BUY	$8.86 - $15.69 $2.1 Million - $3.72 Million	237,015 Added 36.59%	884,786 $13.3 Million
Q1 2020 May 14, 2020	SELL	$6.63 - $11.16 $261,149 - $439,581	-39,389 Reduced 5.73%	647,771 $5.99 Million
Q4 2019 Feb 12, 2020	BUY	$7.48 - $10.75 $1.76 Million - $2.53 Million	235,788 Added 52.24%	687,160 $6.69 Million
Q3 2019 Nov 13, 2019	BUY	$8.02 - $13.25 $213,789 - $353,205	26,657 Added 6.28%	451,372 $3.62 Million
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $857,510 - $1.13 Million	78,240 Added 22.58%	424,715 $5.3 Million
Q1 2019 May 14, 2019	SELL	$10.04 - $13.92 $76,504 - $106,070	-7,620 Reduced 2.15%	346,475 $0
Q4 2018 Feb 13, 2019	SELL	$8.38 - $13.44 $2.61 Million - $4.19 Million	-311,796 Reduced 46.82%	354,095 $3.39 Million
Q3 2018 Nov 02, 2018	BUY	$11.6 - $16.54 $751,018 - $1.07 Million	64,743 Added 10.77%	665,891 $8.05 Million
Q2 2018 Aug 08, 2018	BUY	$13.13 - $17.09 $4.75 Million - $6.18 Million	361,762 Added 151.12%	601,148 $9.39 Million
Q1 2018 May 03, 2018	BUY	$13.76 - $17.12 $1.92 Million - $2.38 Million	139,179 Added 138.89%	239,386 $3.6 Million
Q4 2017 Feb 02, 2018	BUY	$12.51 - $16.24 $173,626 - $225,394	13,879 Added 16.08%	100,207 $1.44 Million
Q3 2017 Nov 01, 2017	BUY	$11.74 - $15.78 $1.01 Million - $1.36 Million	86,328	86,328 $1.3 Million

Others Institutions Holding FOLD

# of Institutions

311

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Amicus Therapeutics, Inc. Transaction History